Interfaith Center on Corporate Responsibility: Shareholders Press Pharma Companies Accepting Public Funds to Prioritize Access, Affordability in Development of COVID-19 Medicine
December 02, 2020
December 02, 2020
NEW YORK, Dec. 2 -- The Interfaith Center on Corporate Responsibility issued the following news release on Dec. 1:
Members of the Interfaith Center on Corporate Responsibility today announced that shareholder proposals have been filed at six pharmaceutical companies in an effort to learn how the companies will price COVID medicine developed with public monies.
Eli Lilly ($LLY), Gilead ($GILD), J&J ($JNJ), Merck ($MRK), Pfizer ($PFE) and Regeneron ($REGN) all receive . . .
Members of the Interfaith Center on Corporate Responsibility today announced that shareholder proposals have been filed at six pharmaceutical companies in an effort to learn how the companies will price COVID medicine developed with public monies.
Eli Lilly ($LLY), Gilead ($GILD), J&J ($JNJ), Merck ($MRK), Pfizer ($PFE) and Regeneron ($REGN) all receive . . .